Your session is about to expire
← Back to Search
Other
Capsaicinoid for Drug Tolerance
Phase 1
Waitlist Available
Led By S Mark Taylor, MD FRCSC
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment and immediate (1 hour after treatment)
Awards & highlights
Study Summary
This trial is testing whether capsaicin can reduce the symptoms of rhinitis.
Eligible Conditions
- Drug Tolerance
- Allergic Rhinitis
- Capsaicin
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-treatment and immediate (1 hour after treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment and immediate (1 hour after treatment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Lacrimation - Likert - Change from 1 hour after pre-treatment baseline
Lacrimation - Likert - Change from 1 week after pre-treatment baseline
Pain - Likert - Change from 1 hour after pre-treatment baseline
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Intranasal CapsaicinExperimental Treatment1 Intervention
Separate patients will be given escalating doses of intranasal capsaicinoid spray
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
257 Previous Clinical Trials
83,784 Total Patients Enrolled
S Mark Taylor, MD FRCSCPrincipal InvestigatorDalhousie University
David WA Forner, MDStudy DirectorDalhousie University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger